Adding an Electrocardiogram to the Pre-participation Examination in Competitive Athletes: A Systematic Review

Current Problems in Cardiology

Volumn 34, Issue 12, 2009, Pages 586-662

  Perez, Marco ^a   Fonda, Holly ^a   Le, Vy Van ^a   Mitiku, Teferi ^a   Ray, Jeremiah ^a   Freeman, James V ^a   Ashley, Euan ^a   Froelicher, Victor F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CISAPRIDE; HALOPERIDOL; ION CHANNEL; NEUROLEPTIC AGENT; TERFENADINE; VERAPAMIL;

ANAMNESIS; ANGIOCARDIOGRAPHY; AORTA STENOSIS; ARTICLE; ATHLETE; BRUGADA SYNDROME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMPETITION; CORONARY ARTERY DISEASE; DEFIBRILLATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; DISEASE REGISTRY; DISEASE SEVERITY; ECG ABNORMALITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FALSE POSITIVE RESULT; FAMILY HISTORY; GENE MUTATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART BLOCK; HEART DEATH; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE FIBROSIS; HEART RIGHT BUNDLE BRANCH BLOCK; HEART RIGHT VENTRICLE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEAT STROKE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; LONG QT SYNDROME; MEDICAL EXAMINATION; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; RADIOFREQUENCY ABLATION; SENSITIVITY AND SPECIFICITY; SPORTS MEDICINE; SUDDEN DEATH; SYMPTOM; SYNCOPE; SYSTEMATIC REVIEW; THORAX BLUNT TRAUMA; TRAINING; UNITED STATES; WOLFF PARKINSON WHITE SYNDROME;

ATHLETES; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MASS SCREENING; REVIEW LITERATURE AS TOPIC;

EID: 70350783821     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2009.08.002     Document Type: Article

References (127)

1. Corrado D., Pelliccia A., Bjornstad H.H., et al. Pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and The Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. G Eur Heart J 26 5 (2005) 516-524
2. Maron B.J., Douglas P.S., Graham T.P., et al. Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes. J Am Coll Cardiol 45 8 (2005) 1322-1326
3. Maron B.J., Thompson P.D., Ackerman M.J., et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity and Metabolism: endorsed by the American College of Cardiology foundation. Circulation 115 12 (2007) 1643-1655
4. Chaitman B.R. An ECG should not be included in routine preparticipation screening of young athletes. Circulation 116 22 (2007) 2610-2614
5. Corrado D., Basso C., Schiavon M., et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 339 6 (1998) 364-369
6. Eckart R.E., Scoville S.L., Campbell C.L., et al. Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med 141 11 (2004) 829-834
7. Corrado D., Basso C., and Thiene G. SCD in young people with apparently normal heart. Cardiovasc Res 50 2 (2001) 399-408
8. Maron B.J., Gohman T.E., and Aeppli D. Prevalence of SCD during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol 32 7 (1998) 1881-1884
9. Basavarajaiah S., Shah A., and Sharma S. Sudden cardiac death in young athletes. Heart 93 3 (2007) 287-289
10. Corrado D., Basso C., Schiavon M., et al. Does sports activity enhance the risk of SCD?. J Cardiovasc Med 7 4 (2006) 228-233
11. Maron B.J. The paradox of exercise. N Engl J Med 343 (2000) 1409-1411
12. Curfman G.D. The health benefits of exercise. A critical reappraisal. N Engl J Med 328 (1993) 574-576
13. Curfman G.D. Is exercise beneficial-or hazardous-to your heart?. N Engl J Med 239 (1993) 1730-1731
14. Thompson P.D., Funk E.J., Carleton R.A., et al. Incidence of death during jogging in Rhode Island from 1975 through 1980. J Am Med Assoc 247 (1982) 2535-2538
15. Siscovick D.S., Weiss N.S., Fletcher R.H., et al. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med 311 (1984) 874-877
16. Willich S.N., Lewis M., Lowel H., et al. Physical exertion as a trigger of acute myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group. N Engl J Med 329 (1993) 1684-1690
17. Mittleman M.A., Maclure M., Tofler G.H., et al., Determinants of Myocardial Infarction Onset Study Investigators. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. N Engl J Med 329 (1993) 1677-1683
18. Corrado D., Basso C., Rizzoli G., et al. Does sports activity enhance the risk of sudden death in adolescents and young adults?. J Am Coll Cardiol 42 11 (2003) 1959-1963
19. Corrado D., Thiene G., Nava A., et al. Sudden death in young competitive athletes: clinico-pathologic correlations in 22 cases. Am J Med 89 (1990) 588-596
20. Basso C., Thiene G., Corrado D., et al. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31 (2000) 988-998
21. Corrado D., Fontaine G., Marcus F.I., et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Need for an international registry. Circulation 101 (2000) e101
22. Corrado D., Basso C., Poletti A., et al. SCD in the young: is coronary thrombosis the major precipitating factor?. Circulation 90 (1994) 2315-2323
23. Maron B.J., Shirani J., Poliac L.C., et al. Sudden death in young competitive athletes. Clinical, demographics, and pathological profiles. J Am Med Assoc 276 (1996) 199-204
24. Antzelevitch C., Brugada P., Borggrefe M., et al. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2 4 (2005) 429-440
25. Miyasaka Y., Tsuji H., Yamada K., et al. Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. J Am Coll Cardiol 38 (2001) 771-774
26. Yoshinaga M., Anan R., Nomura Y., et al. Prevalence and time of appearance of Brugada electrocardiographic pattern in young male adolescents from a three-year follow-up study. Am J Cardiol 94 9 (2004) 1186-1189
27. Sudden, unexpected, nocturnal deaths among Southeast Asian refugees. MMWR. Morb Mortal Wkly Rep 30 (1981) 581-584 589
28. Junttila M.J., Raatikainen M.J., Karjalainen J., et al. Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-aged Finnish population. Eur Heart J 25 10 (2004) 874-878
29. Lee C., Soni A., Tate R.B., et al. The incidence and prognosis of Brugada ECG pattern in the Manitoba follow-up study. Can J Cardiol 21 14 (2005) 1286-1290
30. Eckardt L., Probst V., Smits J.P., et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 111 3 (2005) 257-263
31. Pérez Riera A.R., Antzelevitch C., Schapacknik E., et al. Is there an overlap between Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia?. J Electrocardiol 38 3 (2005) 260-263
32. Di Diego J.M., Fish J.M., and Antzelevitch C. Brugada syndrome and ischemia-induced ST-segment elevation. Similarities and differences. J Electrocardiol 38 suppl (2005) 14-17 (4)
33. Matsuo K., Kurita T., Inagaki M., et al. The circadian pattern to the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J 20 6 (1999) 465-470
34. Corrado D., Basso C., Buja G., et al. Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people. Circulation 103 5 (2001) 710-717
35. Kapetanopoulos A., Kluger J., Maron B.J., et al. The congenital long QT syndrome and implications for young athletes. Med Sci Sports Exerc 38 5 (2006) 816-825
36. Vetter V.L. Clues or miscues?. How to make the right interpretation and correctly diagnose long-QT syndrome. Circulation 115 20 (2007) 2595-2598
37. Taggart N.W., Haglund C.M., Tester D.J., et al. Diagnostic miscues in congenital long-QT syndrome. Circulation 115 20 (2007) 2613-2620
38. Pelliccia A., Culasso F., Di P.F.M., et al. Prevalence of abnormal electrocardiograms in a large, unselected population undergoing pre-participation cardiovascular screening. Eur Heart J 28 16 (2007) 2006-2010
39. Basavarajaiah S., Wilson M., Whyte G., et al. Prevalence and significance of an isolated long QT interval in elite athletes. Eur Heart J 28 23 (2007) 2944-2949
40. Turkmen M., Barutcu I., Esen A.M., et al. Assessment of QT interval duration and dispersion in athlete's heart. J Int Med Res 32 6 (2004) 626-632
41. Schwartz P.J., Priori S.G., Spazzolini C., et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103 1 (2001) 89-95
42. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary. A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48 5 (2006) 1064-1108
43. Wolff L., Parkinson J., and White P. Bundle branch block with short PR interval in healthy young people prone to paroxysmal tachycardia. Am Heart J 5 (1930) 685-704
44. Colavita D., Packer J., Pressley K., et al. Frequency, diagnosis and clinical characteristics of patients with multiple accessory atrioventricular pathways. Am J Cardiol 59 6 (1987) 601-606
45. Basso C., Corrado D., Rossi L., et al. Ventricular preexcitation in children and young adults: atrial myocarditis as a possible trigger of SCD. Circulation 103 2 (2001) 269-275
46. Sarubbi B., Scognamiglio G., Limongelli G., et al. Asymptomatic ventricular pre-excitation in children and adolescents: a 15 year follow up study. Heart 89 2 (2003) 215-217
47. Klein G.J., Yee R., and Sharma A.D. Longitudinal electrophysiological assessment of asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern. N Engl J Med 320 (1989) 1229-1233
48. Krahn A.D., Mandfreda J., Tate R.B., et al. The natural history of electrocardiographic prereexcitation in men. The Manitoba follow-up study. Ann Intern Med 116 (1992) 456-460
49. Sharma A.D., Klein G.J., Guiraudon G.M., et al. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway. Circulation 72 (1985) 161-169
50. Robinson K., Rowland E., and Krikler D.M. Wolff-Parkinson-White syndrome: atrial fibrillation as the presenting arrhythmia. Br Heart J 59 (1988) 578-580
51. Pietersen A.H., Andersen E.D., and Sandoe E. Atrial fibrillation in the Wolff-Parkinson-White syndrome. Am J Cardiol 70 (1992) 38-43A
52. Munger T.M., Packer D.L., Hammill S.C., et al. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-89. Circulation 87 3 (1993) 866-873
53. Goudevenos J.A., Katsouras C.S., Graekas G., et al. Ventricular pre-excitation in the general population: a study on the mode of presentation and clinical course. Heart 83 1 (2000) 29-34
54. Fitzsimmons P.J., McWhirter P.D., Peterson D.W., et al. The natural history of Wolff-Parkinson-White syndrome in 228 military aviators: a long-term follow-up of 22 years. Am Heart J 142 3 (2001) 530-536
55. Timmermans C., Smeets J., Rodriguez L.M., et al. Aborted SCD in the Wolff-Parkinson-White syndrome. Am J Cardiol 76 (1995) 492-494
56. Klein G.J., Prystowsky E.N., Yee R., et al. Asymptomatic Wolff-Parkinson-White. Should we intervene?. Circulation 80 (1989) 1902-1905
57. Klein G.J., Bashore T.M., Sellers T.D., et al. Ventricular fibrillation in the Wolff-Parkinson-White's syndrome. N Engl J Med 301 (1979) 1080-1085
58. Montoya P.T., Brugada P., Smeets J., et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. Eur Heart J 12 (1991) 144-150
59. Pappone C., Santinelli V., Rosanio S., et al. Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study. J Am Coll Cardiol 41 2 (2003) 239-244
60. Attoyan C., Haissaguerre M., Dartigues J.F., et al. Ventricular fibrillation in Wolff-Parkinson-White syndrome. Predictive factors. Arch Mal Coeur Vaiss 87 7 (1994) 889-897
61. Lee P.C., Hwang B., Tai C.T., et al. The different electrophysiological characteristics in children with Wolff-Parkinson-White syndrome between those with and without atrial fibrillation. Pacing Clin Electrophysiol 27 2 (2004) 235-239
62. Bromberg B.I., Lindsay B.D., Cain M.E., et al. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce SCD among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol 27 3 (1996) 690-695
63. Sharma A.D., Yee R., Guiraudon G., et al. Sensitivity and specificity of invasive and noninvasive testing for risk of SCD in Wolff-Parkinson-White syndrome. J Am Coll Cardiol 10 2 (1987) 373-381
64. Klein G.J., and Gulamhusein S.S. Intermittent preexcitation in the Wolff-Parkinson-White syndrome. Am J Cardiol 52 3 (1983) 292-296
65. Bille K., Figueiras D., Schamasch P., et al. SCD in athletes: the Lausanne Recommendations. Eur J Cardiovasc Prev Rehabil 13 6 (2006) 859-875
66. Sarubbi B. The Wolff-Parkinson-White electrocardiogram pattern in athletes: how and when to evaluate the risk for dangerous arrhythmias. The opinion of the paediatric cardiologist. J Cardiovasc Med 7 4 (2006) 271-278
67. Link M.S., Homoud M.K., and Wang P.J. Cardiac arrhythmias in the athlete. Cardiol Rev 9 1 (2001) 21-30
68. Coumel P. Autonomic influences in atrial tachyarrhythmias. Vagal influences that are marked in athletes predispose some athletes to certain types of atrial tachycardias and AF. J Cardiovasc Electrophysiol 7 (1996) 999-1007
69. Furlanello F., Bertoldi A., Dallago M., et al. Atrial fibrillation in elite athletes. J Cardiovasc Electrophysiol 9 suppl (1998) S63-S68 (8)
70. Mont L., Sambola A., Brugada J., et al. Long-lasting sport practice and lone atrial fibrillation. Eur Heart J 23 6 (2002) 477-482
71. Pelliccia A., Maron B.J., Di P.F.M., et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol 46 4 (2005) 690-696
72. Hoogsteen J., Schep G., Van Hemel N.M., et al. Paroxysmal atrial fibrillation in male endurance athletes. A 9-year follow up. Europace 6 3 (2004) 222-228
73. Baldesberger S., Bauersfeld U., Candinas R., et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J 29 1 (2008) 71-78
74. Adabag A., Selcuk A., and Maron B.J. Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy. Ann Noninvasive Electrocardiol 12 2 (2007) 171-180
75. Pelliccia A. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J 27 18 (2006) 2196-2200
76. Basavarajaiah S., Shah A., and Sharma S. Sudden cardiac death in young athletes. Heart 93 3 (2007) 287-289
77. Basavarajaiah S., Wilson M., Whyte G., et al. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. JACC 51 10 (2008) 1033-1039
78. Dollar A.L., and Roberts W.C. Usefulness of total 12-lead QRS voltage compared with other criteria for determining left ventricular hypertrophy in hypertrophic cardiomyopathy: analysis of 57 patients studied at necropsy. Am J Med 87 4 (1989) 377-381
79. Maron B.J., Carney K.P., Lever H.M., et al. Relationship of race to SCD in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol 41 6 (2003) 974-980
80. Maron B.J., Shen W.K., Link M.S., et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 365-373
81. Zipes D., Camm A., Borggrefe M., et al. Ventricular arrhythmias and the prevention of sudden cardiac death. (Writing Committee to Develop guidelines for management of patients with the European Society of Cardiology Committee for Practice Guidelines American College of Cardiology/American Heart Association Task Force and Arrhythmias and the Prevention of Sudden Cardiac Death). A report of the ACC/AHA/ESC 2006 guidelines for management of patients with ventricular. J Am Coll Cardiol 48 (2006) 247-346
82. Maron B.J., Estes III N.A., Maron M.S., et al. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation 107 (2003) 2872-2875
83. Maron B., Maron M., Lesser J., et al. Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status. Am J Cardiol 101 4 (2008) 544-547
84. Ostman-Smith I., Wettrell G., Keeton B., et al. Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly. Cardiol Young 15 6 (2005) 632-642
85. Montgomery J.V., Harris K.M., Casey S.A., et al. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol 96 2 (2005) 270-275
86. Pelliccia F., Cianfrocca C., Cristofani R., et al. ECG findings in patients with hypertrophic cardiomyopathy. Relation to presenting features and prognosis. J Electrocardiol 23 3 (1990) 213-222
87. Bongioanni S., Bianchi F., Migliardi A., et al. Relation of QRS duration to mortality in a community-based cohort with hypertrophic cardiomyopathy. Am J Cardiol 100 3 (2007) 503-506
88. Yi G., Elliott P., McKenna W.J., et al. QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy. Am J Cardiol 82 12 (1998) 1514-1519
89. Pelliccia A., Fernando M., Di Paolo M., et al. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med 358 (2008) 152-161
90. Dumont C.A., Monserrat L., Soler R., et al. Interpretation of electrocardiographic abnormalities in hypertrophic cardiomyopathy with cardiac magnetic resonance. Eur Heart J 27 14 (2006) 1725-1731
91. Maron B.J., Zipes D., and 36th Bethesda Conference. Eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 45 8 (2005) 1340-1341
92. Marcus F.I., Fontaine G.H., Guiraudon G., et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation 65 (1982) 384-398
93. Danieli G.A., and Rampazzo A. Genetics of arrhythmogenic right ventricular cardiomyopathy. Curr Opin Cardiol 17 3 (2002) 218-221
94. Nasir K., Bomma C., Tandri H., et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation 110 12 (2004) 1527-1534
95. Marcus F.I. Prevalence of T-wave inversion beyond V1 in young normal individuals and usefulness for the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Am J Cardiol 95 9 (2005) 1070-1071
96. Gemayel C., Pelliccia A., and Thompson P.D. Arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 38 7 (2001) 1773-1781
97. Furlanello F., Bertoldi A., Dallago M., et al. Cardiac arrest and sudden death in competitive athletes with arrhythmogenic right ventricular dysplasia. Pacing Clin Electrophysiol 21 (1998) 331-335
98. Hulot J.S., Jouven X., Empana J.P., et al. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 110 (2004) 1879-1884
99. Kirchhof P., Fabritz L., Zwiener M., et al. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 114 (2006) 1799-1806
100. Daubert C., Vauthier M., Carré F., et al. Influence of exercise and sport activity on functional symptoms and ventricular arrhythmias in arrhythmogenic right ventricular disease. [Abstract]. J Am Coll Cardiol 23 suppl (1994) 34A
101. Maron B.J., Bodison S.A., Wesley Y.E., et al. Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease. J Am Coll Cardiol 10 6 (1987) 1214-1221
102. Choo J.K., Abernethy III W.B., and Hutter Jr. A.M. Electrocardiographic observations in professional football players. Am J Cardiol 90 2 (2002) 198-200
103. Fuller C.M., McNulty C.M., Spring D.A., et al. Prospective screening of 5,615 high school athletes for risk of SCD. Med Sci Sports Exerc 29 9 (1997) 1131-1138
104. Sharma S., Whyte G., Elliott P., et al. Electrocardiographic changes in 1000 highly trained junior elite athletes. Br J Sports Med 33 5 (1999) 319-324
105. Wilson M.G., Basavarajaiah S., Whyte G., et al. Efficacy of personal symptom and family history questionnaires when screening for inherited cardiac pathologies?. The role of electrocardiography. Br J Sports Med 42 3 (2008) 207-211
106. Tanaka Y., Yoshinaga M., Anan R., et al. Usefulness and cost effectiveness of cardiovascular screening of young adolescents. Med Sci Sports Exerc 38 (2006) 2-6
107. Corrado D., Basso C., Pavei A., et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. J Am Med Assoc 296 13 (2006) 1593-1601
108. Bjornstad H., Storstein L., Meen H.D., et al. Electrocardiographic findings in athletic students and sedentary controls. Cardiology 79 4 (1991) 290-305
109. Bjørnstad H., Storstein L., Dye Meen H., et al. ECG findings of heart rate and conduction times in athletic students and sedentary control subjects. Cardiology 83 4 (1993) 258-267
110. Bjornstad H., Smith G., Storstein L., et al. Electrocardiographic and echocardiographic findings in top athletes, athletic students and sedentary controls. Cardiology 82 1 (1993) 66-74
111. Langdeau J.B., Blier L., Turcotte H., et al. Electrocardiographic findings in athletes: the prevalence of left ventricular hypertrophy and conduction defects. Can J Cardiol 17 6 (2001) 655-659
112. Turkmen M., Barutcu I., Esen A.M., et al. Assessment of QT interval duration and dispersion in athlete's heart. J Int Med Res 32 6 (2004) 626-632
113. Bjornstad H., Storstein L., Dye Meen H., et al. Electrocardiographic findings according to level of fitness and sport activity. Cardiology 83 4 (1993) 268-279
114. Pelliccia A., Maron B.J., Culasso F., et al. Clinical Signficance of abnormal electrocardiographic pattern in trained athletes. Circulation 102 (2000) 278-284
115. Roeske W.R., O'Rourke R.A., Klein A., et al. Noninvasive evaluation of ventricular hypertrophy in professional athletes. Circulation 53 2 (1976) 286-291
116. Mumford M., and Prakash R. Electrocardiographic and echocardiographic characteristics of long distance runners. Comparison of left ventricular function with age- and sex-matched controls. Am J Sports Med 9 1 (1981) 23-28
117. Zakynthinos E., Vassilakopoulos T., Mavrommati I., et al. Echocardiographic and ambulatory electrocardiographic findings in elite water-polo athletes. Scand J Med Sci Sports 11 3 (2001) 149-155
118. Storstein L., Bjornstad H., Hals O., et al. Electrocardiographic findings according to sex in athletes and controls. Cardiology 79 3 (1991) 227-236
119. George K.P., Wolfe L.A., Burggraf G.W., et al. Electrocardiographic and echocardiographic characteristics of female athletes. Med Sci Sports Exerc 27 10 (1995) 1362-1370
120. Moroe K., Kimoto K., Inoue T., et al. Evaluation of abnormal signal-averaged electrocardiograms in young athletes. Jpn Circul J 59 5 (1995) 247-256
121. Lonati L.M., Magnaghi G., Bizzi C., et al. Patterns of QT dispersion in athletic and hypertensive left ventricular hypertrophy. Ann Noninvasive Electrocardiol 9 3 (2004) 252-256
122. Huston T.P., Puffer J.C., and Rodney W.M. The athletic heart syndrome. N Engl J Med 313 (1985) 24
123. Douglas P.S., O'Toole M.L., Hiller W.D., et al. Echocardiographic and ECG findings in athletes. Am Heart J 116 3 (1988) 784-790
124. Pelliccia A., Di P.F.M., and Maron B.J. The athlete's heart: remodeling, electrocardiogram and preparticipation screening. Cardiol Rev 10 2 (2002) 85-90
125. Björnstad H., Storstein L., Meen H.D., et al. Electrocardiographic findings of left, right and septal hypertrophy in athletic students and sedentary controls. Cardiology 82 1 (1993) 56-65
126. Maron B.J., Doerer J.J., Haas T.S., et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation 119 (2009) 1085-1092
127. Corrado D., Basso C., Schiavon M., et al. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death. J Am Coll Cardiol 52 (2008) 1981-1989